Safety and effectiveness of IV Thrombolysis in retinal artery occlusion: A multicenter retrospective cohort study.

Publikation

Safety and effectiveness of IV Thrombolysis in retinal artery occlusion: A multicenter retrospective cohort study.

Wissenschaftlicher Artikel/Review - 07.07.2023

Baumgartner Philipp, Kook Lucas, Altersberger Valerian L, Gensicke Henrik, Ardila Jurado Elena, Kägi Georg, Salerno Alexander, Michel Patrik, Gopisingh Kiran M, Nederkoorn Paul J J, Scheitz Jan F, Nolte Christian H, Heldner Mirjam R, Arnold Marcel, Cordonnier Charlotte, Della Schiava Lucie, Hametner Christian, Ringleb Peter Arthur, Leker Ronen R, Jubran Hamza, Luft Andreas R, Engelter Stefan T, Wegener Susanne, Thrombolysis in Stroke Patients (TRISP) Collaborators

Zitation

Baumgartner P, Kook L, Altersberger V, Gensicke H, Ardila Jurado E, Kägi G, Salerno A, Michel P, Gopisingh K, Nederkoorn P, Scheitz J, Nolte C, Heldner M, Arnold M, Cordonnier C, Della Schiava L, Hametner C, Ringleb P, Leker R, Jubran H, Luft A, Engelter S, Wegener S, Thrombolysis in Stroke Patients (TRISP) Collaborators. Safety and effectiveness of IV Thrombolysis in retinal artery occlusion: A multicenter retrospective cohort study. Eur Stroke J 2023; 8:966-973.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Eur Stroke J 2023; 8

Veröffentlichungsdatum

07.07.2023

eISSN (Online)

2396-9881

Seiten

966-973

Kurzbeschreibung/Zielsetzung

Retinal artery occlusion (RAO) may lead to irreversible blindness. For acute RAO, intravenous thrombolysis (IVT) can be considered as treatment. However, due to the rarity of RAO, data about IVT safety and effectiveness is limited.